• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Teva Pharmaceutical Industries

Teva Pharmaceutical Industries

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Research
  1. Teva Files 2016 Annual Report on Form 20-F

    Teva Files 2016 Annual Report on Form 20-F

  2. Eagle Pharmaceuticals Announces New Patents Issued for Bendeka

    Eagle Pharmaceuticals Announces New Patents Issued for Bendeka

  3. North American Intrauterine Contraceptive Devices (IUCD) Market - Opportunities and Forecast, 2014 - 2022 - Research and Markets

    North American Intrauterine Contraceptive Devices (IUCD) Market - Opportunities and Forecast, 2014 - 2022 - Research and Markets

  4. Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman

    Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman

  5. Teva Confirms District Court Decision in COPAXONE® 40 mg/mL Patent Trial

    Teva Confirms District Court Decision in COPAXONE® 40 mg/mL Patent Trial

  6. Teva CEO Erez Vigodman to Step Down

    Teva CEO Erez Vigodman to Step Down

  7. Teva shares fall as court invalidates patent infringement claims

    Teva shares fall as court invalidates patent infringement claims

  8. Contraceptives - Global Strategic Business Report, 2015-2022 with Reckitt Benckiser, Ansell, Church & Dwight Leading the Way - Research and Markets

    Contraceptives - Global Strategic Business Report, 2015-2022 with Reckitt Benckiser, Ansell, Church & Dwight Leading the Way - Research and Markets

  9. MARKET SNAPSHOT: Dow Rises By Triple Digits As Stock Market Carves Out Records

    MARKET SNAPSHOT: Dow Rises By Triple Digits As Stock Market Carves Out Records

  10. UPDATE: Dow rises by triple digits as stock market carves out records

    UPDATE: Dow rises by triple digits as stock market carves out records

12345

©2017 Morningstar Advisor. All right reserved.